🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 18 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/09/2013 | 27,42 | 28,08 | 26,96 | 27,46 | -0,25% | 4,12% | 344.966 |
| 23/09/2013 | 28,48 | 28,55 | 27,00 | 27,53 | -3,33% | 5,43% | 1.181.411 |
| 20/09/2013 | 28,92 | 29,13 | 27,81 | 28,48 | -1,55% | 4,55% | 1.343.474 |
| 19/09/2013 | 29,21 | 29,34 | 28,88 | 28,93 | -1,13% | 1,56% | 137.698 |
| 18/09/2013 | 29,15 | 29,62 | 29,11 | 29,26 | -0,21% | 1,76% | 179.376 |
| 17/09/2013 | 29,19 | 29,57 | 29,03 | 29,32 | +0,49% | 1,86% | 180.658 |
| 16/09/2013 | 29,62 | 29,86 | 29,12 | 29,18 | -0,51% | 2,51% | 205.024 |
| 13/09/2013 | 29,23 | 29,46 | 28,45 | 29,33 | +0,97% | 3,44% | 228.428 |
| 12/09/2013 | 29,27 | 29,68 | 28,80 | 29,05 | -1,02% | 3,01% | 499.174 |
| 11/09/2013 | 29,30 | 29,63 | 28,83 | 29,35 | -0,02% | 2,73% | 340.798 |
| 10/09/2013 | 30,25 | 30,51 | 29,14 | 29,35 | -2,33% | 4,52% | 352.820 |
| 09/09/2013 | 28,70 | 30,11 | 28,50 | 30,05 | +5,45% | 5,59% | 175.849 |
| 06/09/2013 | 28,83 | 29,10 | 27,53 | 28,50 | -1,57% | 5,43% | 370.453 |
| 05/09/2013 | 29,56 | 30,03 | 28,33 | 28,95 | -2,56% | 5,74% | 284.693 |
| 04/09/2013 | 30,27 | 30,87 | 29,61 | 29,71 | -1,67% | 4,16% | 688.328 |
| 03/09/2013 | 30,12 | 30,56 | 29,49 | 30,22 | +0,73% | 3,52% | 382.155 |
| 30/08/2013 | 30,47 | 30,87 | 29,45 | 30,00 | -1,84% | 4,65% | 568.744 |
| 29/08/2013 | 29,04 | 30,69 | 28,84 | 30,56 | +5,67% | 6,36% | 343.683 |
| 28/08/2013 | 28,19 | 29,08 | 28,10 | 28,92 | +2,68% | 3,45% | 226.023 |
| 27/08/2013 | 28,17 | 28,38 | 27,49 | 28,17 | -1,63% | 3,17% | 380.232 |
| 26/08/2013 | 27,76 | 29,04 | 27,70 | 28,63 | +3,47% | 4,83% | 240.290 |
| 23/08/2013 | 27,40 | 27,78 | 27,00 | 27,67 | +1,46% | 2,85% | 127.118 |
| 22/08/2013 | 27,29 | 27,72 | 26,82 | 27,27 | -0,02% | 3,29% | 82.715 |
| 21/08/2013 | 27,17 | 27,60 | 26,66 | 27,28 | +0,18% | 3,47% | 162.705 |
| 20/08/2013 | 26,66 | 27,47 | 26,51 | 27,23 | +2,01% | 3,58% | 188.994 |
| 19/08/2013 | 26,82 | 27,24 | 26,43 | 26,69 | -0,63% | 3,02% | 232.114 |
| 16/08/2013 | 25,98 | 27,40 | 25,76 | 26,86 | +3,36% | 6,29% | 365.484 |
| 15/08/2013 | 26,99 | 27,32 | 25,83 | 25,99 | -5,08% | 5,55% | 173.765 |
| 14/08/2013 | 27,33 | 27,84 | 27,24 | 27,38 | +0,32% | 2,19% | 144.270 |
| 13/08/2013 | 27,45 | 27,97 | 27,17 | 27,29 | +0,09% | 2,89% | 191.078 |